SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum

COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we measured the metabolomic and lipidomic serum profile from 263 (training cohort) + 135 (validation cohort) symptomatic patients hospitalized after positive PCR testing for SARS-CoV-2 infection. We also established the profiles of 280 persons collected before the coronavirus pandemic started. Principal-component analysis discriminated both cohorts, highlighting the impact that the infection has on overall metabolism. The lipidomic analysis unraveled a pathogenic redistribution of the lipoprotein particle size and composition to increase the atherosclerotic risk. In turn, metabolomic analysis reveals abnormally high levels of ketone bodies (acetoacetic acid, 3-hydroxybutyric acid, and acetone) and 2-hydroxybutyric acid, a readout of hepatic glutathione synthesis and marker of oxidative stress. Our results are consistent with a model in which SARS-CoV-2 infection induces liver damage associated with dyslipidemia and oxidative stress. [Display omitted] •Metabolomic and lipidomic serum profile of 398 COVID-19 acute-phase patients•Severe dyslipidemia that affects lipoprotein particle size and distribution•Central metabolism dysregulation and ketone bodies accumulation•Succinic upregulation resembles the pseudohypoxic environment in cancer Human Metabolism; Virology; Metabolomics